Attached files

file filename
EX-99 - INVESTOR PRESENTATION - Corindus Vascular Robotics, Inc.ex99-1.htm

 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

 


 

FORM 8-K

 

CURRENT REPORT 

PURSUANT TO SECTION 13 OR 15(d) OF THE 

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): September 8, 2016 

 

CORINDUS VASCULAR ROBOTICS, INC.


 (Exact Name of Registrant as Specified in its Charter)

 

  Delaware   001-37406   30-0687898
  (State or Other
Jurisdiction of Incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

309 Waverley Oaks Road, Suite 105

Waltham, MA 02452


 (Address of Principal Executive Office) (Zip Code) 

 

Registrant’s telephone number, including area code: (508) 653-3335

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

Item 7.01     Regulation FD Disclosure.

 

Corindus Vascular Robotics, Inc. is furnishing as Exhibit 99.1 to this Current Report on Form 8-K an investor presentation which will be used, in whole or in part, and subject to modification, on September 8, 2016 and at subsequent meetings with investors or analysts.

 

The information in this Current Report on Form 8-K (including the exhibit) is being furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor will any of such information or exhibits be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except as expressly set forth by specific reference in such filing.

 

Item 9.01     Financial Statements and Exhibits

 

(d) Exhibits.

 

Exhibit Number   Description
     
99.1   Corindus Vascular Robotics, Inc. investor presentation dated September 2016.

 

 

 
 

 

SIGNATURES

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Date: September 8, 2016 CORINDUS VASCULAR ROBOTICS, INC.
     
  By: /s/ David W. Long
  Name: David W. Long
  Title: Chief Financial Officer